Cargando…
2706. Effectiveness and Safety of Shingrix Vaccination in Solid Organ Transplant Recipients at a Large Urban Transplant Center
BACKGROUND: The varicella zoster virus (VZV) recombinant subunit vaccine, Shingrix, was found to be safe in solid organ transplant recipients (SOTR) and is now approved and recommended for all immunocompromised patients. Given limited efficacy data, we preferred a single center retrospective study t...
Autores principales: | Halkett, Megan, Ison, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679076/ http://dx.doi.org/10.1093/ofid/ofad500.2317 |
Ejemplares similares
-
1754. Pre-Transplant Vaccination Rates in Solid-Organ Transplant Recipients
por: Friedman, Daniel, et al.
Publicado: (2019) -
Reactivation of Herpes Zoster Keratitis Following Shingrix Vaccine
por: Lu, Tracy J., et al.
Publicado: (2022) -
Infections in Solid-Organ Transplant Recipients
por: Singh, Nina, et al.
Publicado: (2015) -
Vaccination Recommendations in Solid Organ Transplant Adult Candidates and Recipients
por: Viganò, Mauro, et al.
Publicado: (2023) -
Approach to vaccinating the pediatric solid organ transplant candidate and recipient
por: Kao, Carol M., et al.
Publicado: (2023)